scorecardresearch
Monday, May 6, 2024
TopicPfizer

Topic: Pfizer

Pfizer Covid vaccine’s funding came from Berlin, not Washington

Berlin gave the German company $445 million in an agreement in September to help accelerate the vaccine by building out manufacturing & development capacity in its home market.

The Turkish-German doctor couple behind BioNTech and Pfizer’s promising Covid vaccine

Ugur Sahin is chief executive at BioNTech, while Oezlem Tuereci is a fellow board member. Both are children of Turkish immigrants in Germany.

Why Pfizer vaccine success offers real optimism in the fight against Covid

Pfizer and BioNTech announced Monday that their vaccine candidate prevented over 90% of Covid-19 cases in an early look at results from their 44,000-person clinical trial.

‘Best news’ so far on Covid vaccine – Pfizer shot prevents 90% of infections in large study

With effectiveness for first vaccines previously expected to be in range of 60% to 70%, more than 90% for Pfizer’s Covid vaccine is seen as extraordinary.

Pfizer targeting November end for Covid vaccine application, could seek emergency approval

US FDA requires that people in the vaccine study be watched for side-effects for 2 months, so safety reviews will dictate timeline, Pfizer CEO says.

Pfizer-BioNTech Covid vaccine trial on track, CEO says study didn’t stop over safety concerns

Pfizer and BioNTech on track to potentially be the first to show the efficacy of a Covid-19 vaccine, in an environment of intense scrutiny over every possible complication.

Why rushing a Covid vaccine is a terrible idea

A little patience would help deliver much more information and give other vaccine hopefuls, apart from the front-runners, a chance to prove their worth as well.

Americans could get Covid vaccine before the end of this year, Pfizer CEO says

Pfizer chief Albert Bourla says his firm and its partner BioNTech have a 60% chance of knowing the efficacy of their still experimental vaccine by end of October.

Pfizer’s Covid vaccine is on track for regulatory review in October

Pfizer and BioNTech last month clinched a $2 billion deal to supply an initial 100 million doses of the vaccine to the US.

US orders up to 600 million doses of Pfizer, BioNTech Covid vaccine

The US will pay the companies when it receives the doses, following regulatory authorization or approval, according to a statement Wednesday.

On Camera

Azad, Antony, Geetha—6 candidates to watch in 2024. Their win can reshape politics in states

While Chandra Shekhar Azad is a streetfighter who has caught the fancy of Dalit youth, Anil Antony is the face of the BJP’s fresh social engineering attempt.

Air India reduces baggage allowance by 5-15 kg, bringing it in line with rest of industry

Air India’s new policy, effective from 2 May, introduces new weight limits for tickets in each of the different 'fare families' — Comfort, Comfort Plus, and Flex.

China builds road through Shaksgam Valley, India registers protest

New Delhi has, in past, too, objected to Chinese construction activities in Shaksgam Valley. Work in this strategic region gathered pace after the 2017 Doklam stand-off.

Frontrunner is letting the challenger define this poll campaign. Modi still hasn’t found a big theme

A theme has not yet emerged for BJP & people see lack of a contest, which makes it unexciting. For all these reasons, 2024 is turning out to be an unexpectedly theme-less election.